Contribution of intravenous immunoglobulins to the treatment of myasthenia

  • Gajdos P
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Myasthenia gravis is an autoimmune disease characterized by the production of autoantibodies against acetylcholine receptors at the end plate of the neuromuscular synapse.

Cite

CITATION STYLE

APA

Gajdos, P. (2001). Contribution of intravenous immunoglobulins to the treatment of myasthenia. Neurology Bulletin, XXXIII(1–2), 114–115. https://doi.org/10.17816/nb79794

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free